Track topics on Twitter Track topics that are important to you
AmorChem is pleased to announce the addition of Fondaction to the limited partners of the AmorChem II Fund L.P. The fund initially closed on September 19, 2017, having raised capi...
Inversago Pharma Inc. raised $7mm through its Series A financing co-led by Genesys Capital and AmorChem, which were joined by JDRF T1D Fund, Accel-Rx, Anges Québec Capital, Tarnagulla Ventures, and a...
Proceeds will support the development of new generations of cannabinoid-1 (CB1) receptor inverse agonists for the treatment of several metabolic diseases including Prader-Willi Sy...
AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...
We have published hundreds of AmorChem news stories on BioPortfolio along with dozens of AmorChem Clinical Trials and PubMed Articles about AmorChem for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AmorChem Companies in our database. You can also find out about relevant AmorChem Drugs and Medications on this site too.